{"denoms":[{"counts":[{"groupId":"BG000","value":"1018"},{"groupId":"BG001","value":"1015"},{"groupId":"BG002","value":"1014"},{"groupId":"BG003","value":"3047"}],"units":"Participants"}],"groups":[{"description":"Tamoxifen 20mg orally daily for 5 years","id":"BG000","title":"Tamoxifen"},{"description":"Tamoxifen 20mg orally daily for 5 years plus ovarian function suppression (OFS; triptorelin (GnRH analogue) 3.75 mg by im injection q28 days for 5 years; or surgical oophorectomy; or ovarian irradiation)","id":"BG001","title":"T+OFS"},{"description":"Exemestane 25mg orally daily for 5 years plus ovarian function suppression (OFS; triptorelin (GnRH analogue) 3.75 mg by im injection q28 days for 5 years; or surgical oophorectomy; or ovarian irradiation)","id":"BG002","title":"E+OFS"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"38","upperLimit":"46","value":"43"},{"groupId":"BG001","lowerLimit":"38","upperLimit":"47","value":"43"},{"groupId":"BG002","lowerLimit":"38","upperLimit":"47","value":"43"},{"groupId":"BG003","lowerLimit":"38","upperLimit":"47","value":"43"}]}]}],"dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"100"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"100"},{"groupId":"BG003","value":"300"}]}],"title":"Female"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Male"}],"description":"Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.","paramType":"NUMBER","title":"Sex/Gender, Customized","unitOfMeasure":"percent of participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"9"}]}],"title":"American Indian/Alaskan native"},{"categories":[{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"33"},{"groupId":"BG003","value":"103"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"34"},{"groupId":"BG003","value":"93"}]}],"title":"Black/African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"12"}]}],"title":"Hawaiian/Pacific Islander"},{"categories":[{"measurements":[{"groupId":"BG000","value":"877"},{"groupId":"BG001","value":"873"},{"groupId":"BG002","value":"866"},{"groupId":"BG003","value":"2616"}]}],"title":"White/Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"9"}]}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"22"},{"groupId":"BG003","value":"63"}]}],"title":"Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"48"},{"groupId":"BG002","value":"50"},{"groupId":"BG003","value":"142"}]}],"title":"Hispanic/Latino/South American native"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"65.03"},{"groupId":"BG001","value":"65.22"},{"groupId":"BG002","value":"66.17"},{"groupId":"BG003","value":"196.42"}]}],"title":"Negative"},{"categories":[{"measurements":[{"groupId":"BG000","value":"34.97"},{"groupId":"BG001","value":"34.78"},{"groupId":"BG002","value":"33.83"},{"groupId":"BG003","value":"103.58"}]}],"title":"Positive"}],"description":"Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.","paramType":"NUMBER","title":"Lymph-node status","unitOfMeasure":"percent of participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2.65"},{"groupId":"BG001","value":"2.46"},{"groupId":"BG002","value":"2.07"},{"groupId":"BG003","value":"7.18"}]}],"title":"Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"66.40"},{"groupId":"BG001","value":"64.63"},{"groupId":"BG002","value":"66.86"},{"groupId":"BG003","value":"197.89"}]}],"title":"<=2 cm"},{"categories":[{"measurements":[{"groupId":"BG000","value":"30.94"},{"groupId":"BG001","value":"32.91"},{"groupId":"BG002","value":"31.07"},{"groupId":"BG003","value":"94.92"}]}],"title":">2cm"}],"description":"Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.","paramType":"NUMBER","title":"Tumor size","unitOfMeasure":"percent of participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2.36"},{"groupId":"BG001","value":"2.36"},{"groupId":"BG002","value":"2.17"},{"groupId":"BG003","value":"6.89"}]}],"title":"Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"27.01"},{"groupId":"BG001","value":"26.11"},{"groupId":"BG002","value":"24.36"},{"groupId":"BG003","value":"77.48"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"48.33"},{"groupId":"BG001","value":"50.64"},{"groupId":"BG002","value":"53.65"},{"groupId":"BG003","value":"152.62"}]}],"title":"2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"22.30"},{"groupId":"BG001","value":"20.89"},{"groupId":"BG002","value":"19.82"},{"groupId":"BG003","value":"63.01"}]}],"title":"3"}],"description":"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.\n\nUnits in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.","paramType":"NUMBER","title":"Tumor grade","unitOfMeasure":"percent of participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4.32"},{"groupId":"BG001","value":"2.86"},{"groupId":"BG002","value":"2.66"},{"groupId":"BG003","value":"9.84"}]}],"title":"Unknown"},{"categories":[{"measurements":[{"groupId":"BG000","value":"84.18"},{"groupId":"BG001","value":"85.42"},{"groupId":"BG002","value":"84.52"},{"groupId":"BG003","value":"254.12"}]}],"title":"Negative"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11.49"},{"groupId":"BG001","value":"11.72"},{"groupId":"BG002","value":"12.82"},{"groupId":"BG003","value":"36.03"}]}],"title":"Positive"}],"description":"Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.","paramType":"NUMBER","title":"HER2-status","unitOfMeasure":"percent of participants"}],"populationDescription":"Intention-to-treat population, excludes 19 patients who immediately withdrew consent."}